pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
duvelisib
Copiktra (duvelisib)
T-Cell Lymphomas
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Secura Bio Inc
0 catalysts
Preclinical
edodekin alfa SR
edodekin alfa
Pancreatic Cancer
TherapyX Inc
0 catalysts
Phase 2
efarindodekin alfa
efarindodekin alfa[INN]
← prev
page 45 of 62
next →
131
Pain89
Neurology1
Cervical Cancer
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 2
efgitasialase alfa
Breast Cancer
Palleon Pharmaceuticals Inc
0 catalysts
Phase 2
efineptakin alfa
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
NeoImmuneTech Inc
0 catalysts
Phase 3
eflornithine
eflornithine [INN]
Anaplastic Astrocytoma
Orbus Therapeutics Inc
0 catalysts
Phase 3
eftilagimod alfa
eftilagimod alfa [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$IMMPIMMUTEP Ltd
0 catalysts
Marketed
elacestrant hydrochloride
Orserdu (elacestrant hydrochloride)
Metastatic Breast Cancer
Estrogen receptor
A. Menarini Industrie Farmaceutiche Riunite Srl
0 catalysts
Phase 3
elenestinib
Systemic Mastocytosis
Blueprint Medicines Corp
0 catalysts
Preclinical
elesclomol
Endometrial Cancer
Edison Oncology Holding Corp
0 catalysts
Phase 2
elironrasib
Non-Small Cell Lung Cancer
$RVMDRevolution Medicines, Inc.
0 catalysts
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
0 catalysts
Marketed
elotuzumab
Empliciti (elotuzumab)
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Phase 2
elraglusib
Neuroblastoma
Glycogen synthase kinase-3 beta
$ACTUACTUATE THERAPEUTICS, INC.
0 catalysts
Phase 3
elritercept
Anemia
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
0 catalysts
Phase 2
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 3
emactuzumab
Tenosynovial Giant Cell Tumor
Macrophage colony-stimulating factor 1 receptor
SynOx Therapeutics Ltd
0 catalysts
Phase 1
emaretamig
emaretamig [INN]
Adenocarcinoma Of The Gastroesophageal Junction
$XNCRXencor Inc
0 catalysts
Phase 1
emiltatug ledadotin
emiltatug ledadotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$DAWNDay One Biopharmaceuticals, Inc.
0 catalysts
Phase 1
emunkitug
emunkitug [INN]
Cervical Cancer
HiFiBiO Therapeutics Inc
0 catalysts
Marketed
enasidenib mesylate
Idhifa (enasidenib mesylate)
Refractory Acute Myeloid Leukemia
Bristol-Myers Squibb Co
0 catalysts
Phase 2
endoxifen
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ATOSATOSSA THERAPEUTICS, INC.
0 catalysts
Phase 2
eniluracil
Metastatic Breast Cancer
Dihydropyrimidine dehydrogenase [NADP(+)]
$PCSAProcessa Pharmaceuticals, Inc.
0 catalysts
Phase 2
enozertinib
enozertinib [INN]
Solid Tumor
$ORICOric Pharmaceuticals, Inc.
0 catalysts
Marketed
entrectinib
Rozlytrek (entrectinib)
Non-Small Cell Lung Cancer
ALK tyrosine kinase receptorNeurotrophic tyrosine kinase receptor
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
enzomenib tartrate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Sumitomo Pharma Co Ltd
0 catalysts
Phase 2
epsametostat
epsametostat [INN]
Peripheral T-Cell Lymphomas (PTCL)
Shanghai Haihe Biopharma Co Ltd
0 catalysts
Marketed
eribulin mesylate
Halaven (eribulin mesylate)
Liposarcoma
Eisai Co Ltd
0 catalysts
Marketed
erlotinib hydrochloride
Erlotinib Hydrochloride (erlotinib hydrochloride)
Non-Small Cell Lung Cancer
NATCO Pharma Inc.
0 catalysts